Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 May 22;9(1):7734.
doi: 10.1038/s41598-019-44002-y.

Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial

Affiliations
Randomized Controlled Trial

Improving medication adherence in adult kidney transplantation (IMAKT): A pilot randomised controlled trial

Jac Kee Low et al. Sci Rep. .

Abstract

Resources to support long-term medication adherence in kidney transplantation are limited. This study aimed to determine the efficacy of an intervention designed for kidney transplant recipients to enhance medication adherence. A single-blind, multi-site, 12-month pilot randomised controlled trial was conducted at all five public hospitals providing adult kidney transplantation in Victoria, Australia. Participants were recruited at 4 to 6 weeks post-transplantation. Thirty-five participants were randomly assigned to a 3-month intervention, involving a face-to-face meeting (a medication review and a consumer-centred video) and health coaching every two weeks. Thirty-six were randomised to receive usual care. All participants were followed for nine months post-intervention. There were no differences in adherence between groups measured by Medication Event Monitoring System (MEMS), however, it was underutilised by 42% of participants. Based on the self-reported Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS©) score, the percentage of adherent participants decreased significantly between baseline and 3 to 12 months in the control group (p-values < 0.001) whilst the percentage of adherent participants in the intervention group remained constant over time. No group differences were detected in other outcomes. Due to the complex medication regimen, developing and testing a medication adherence intervention is difficult in kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Flow of participants through the 12-month pilot randomised controlled trial.
Figure 2
Figure 2
Percentage of adherent participants by time between groups. (a) The percentage of adherent participants was defined using the MEMS, as ≥97% of adherence level to both “taking” and “timing” of medication dosing. (b) The percentage of adherent participants was defined using the BAASIS© scoring system. *Denotes p < 0.05; **denotes p < 0.001.

References

    1. Chadban SJ, et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology (Carlton) 2012;17:204–214. doi: 10.1111/j.1440-1797.2011.01559.x. - DOI - PubMed
    1. Weng FL, et al. Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: A cross-sectional study. BMC Nephrol. 2013;14:261. doi: 10.1186/1471-2369-14-261. - DOI - PMC - PubMed
    1. Joost R, Dorje F, Schwitulla J, Eckardt KU, Hugo C. Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: A quasi-experimental study. Nephrol Dial Transplant. 2014;29:1597–1607. doi: 10.1093/ndt/gfu207. - DOI - PubMed
    1. Spivey CA, Chisholm-Burns MA, Damadzadeh B, Billheimer D. Determining the effect of immunosuppressant adherence on graft failure risk among renal transplant recipients. Clin Transplant. 2014;28:96–104. doi: 10.1111/ctr.12283. - DOI - PubMed
    1. Patzer RE, et al. Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients. Clin Transplant. 2016;30:1294–1305. doi: 10.1111/ctr.12821. - DOI - PMC - PubMed

Publication types